Skip to content
10-Q

Quarterly Report

TONGLI PHARMACEUTICALS (USA), INC.

0001144204-13-046860

← back to feed
Filed
Aug 19, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Aug 19, 2013 14.73M sh
Operating Cash Flow Q1 2013 · Jun 30, 2013 $667.2K
Stockholders Equity Q1 2013 · Jun 30, 2013 $20.87M
Stockholders Equity Q1 2013 · Mar 31, 2013 $20.47M
Current Liabilities Q1 2013 · Jun 30, 2013 $963.92K
Current Liabilities Q1 2013 · Mar 31, 2013 $1.59M
Current Assets Q1 2013 · Jun 30, 2013 $2.95M
Current Assets Q1 2013 · Mar 31, 2013 $4.07M
Total Assets Q1 2013 · Jun 30, 2013 $21.84M
Total Assets Q1 2013 · Mar 31, 2013 $22.06M
Sga Expense Q1 2013 · Jun 30, 2013 $153.95K
Net Income Q1 2013 · Jun 30, 2013 $79.49K
Operating Income Q1 2013 · Jun 30, 2013 $135.1K
Gross Profit Q1 2013 · Jun 30, 2013 $371.53K
Cost Of Revenue Q1 2013 · Jun 30, 2013 $379.03K